Loading clinical trials...
Loading clinical trials...
EFFectiveness of Once-weekly Insulin ICodec Versus Once-daily Basal Insulin Analogues in an Insulin-naïve Type 2 diabEtes Population in Real-world cliNical pracTice- The EFFICIENT Pragmatic Study Effectiveness of Insulin Icodec in Real-world Clinical Practice
Conditions
Interventions
Insulin icodec
Basal insulin analogues
Locations
75
Canada
Centricity Research Calgary Endocrinology
Calgary, Alberta, Canada
Alta Clinical Research at Hermitage Medicentre
Edmonton, Alberta, Canada
Fraser Clinical Trials Inc.
New Westminster, British Columbia, Canada
Winnipeg Clinic
Winnipeg, Manitoba, Canada
G.A. Research Associates Ltd.
Moncton, New Brunswick, Canada
Centricity Research Brampton Endocrinology
Brampton, Ontario, Canada
Start Date
August 15, 2025
Primary Completion Date
August 4, 2026
Completion Date
August 31, 2028
Last Updated
April 6, 2026
NCT06513026
NCT06329375
NCT06945406
NCT06959901
NCT06574035
NCT06861062
Lead Sponsor
Novo Nordisk A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions